Medexus Welcomes Two New Board Members
Harmony P. Garges MD MPH and Menassie Taddese MBA appointed to Medexus’s board of directors
Appointments bolster Medexus board’s medical and financial expertise, particularly in the United States
Related news for (MEDXF)
- Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
- Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
- Medexus Announces New License Deal for Topical Terbinafine
- Medexus Announces US$58.5 million in New Credit Facilities
- Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022